TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns

被引:27
作者
Hanada, K
Itoh, M
Fujii, K
Tsuchida, A
Hirata, M
Iwao, T
Eguchi, N
Sasaki, T
Matsubara, K
Kajiyama, G
机构
[1] First Dept. of Internal Medicine, Hiroshima Univ. School of Medicine, Hiroshima 734, 1-2-3 Kasumi, Minami-ku
关键词
gallbladder carcinoma; TP53; growth pattern; stage I; carcinogenesis;
D O I
10.1016/S0959-8049(97)00080-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
32 stage I cases of gallbladder carcinoma (GC) were examined to evaluate TP53 mutations with special attention to growth patterns. Their growth patterns were classified into two types: polypoid (P-type) and flat (F-type). 16 cases of GC were classified as P-type and 16 as F-type. p53 immunohistochemistry was performed using a mouse monoclonal anti-p53 antibody. Mutations in exons 5-8 were examined by polymerase chain reaction single strand conformation polymorphism (PCR-SSCP) and direct sequencing. The incidence of p53 immunoreactivity was greater in the cases of F-type (11/16, 69%) than those in P-type (14/16, 25%) (P < 0.05). PCR-SSCP or direct sequencing revealed that TP53 mutations were detected in all cases positive for p53 protein. These results suggest that TP53 mutations may contribute to the carcinogenesis of the F-type GC, and that this pathway in the F-type may differ from that in the P-type GC. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1136 / 1140
页数:5
相关论文
共 33 条
[1]  
ALBORESSAAVEDRA J, 1984, ATLAS TUMOR PATHOLOG
[2]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[3]  
BEAHRS OH, 1992, MANUAL STAGING CANCE
[4]   COMPARATIVE-ANALYSIS OF MUTATIONS IN THE P53 AND K-RAS GENES IN PANCREATIC-CANCER [J].
BERROZPE, G ;
SCHAEFFER, J ;
PEINADO, MA ;
REAL, FX ;
PERUCHO, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :185-191
[5]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[6]  
CERVANTES M, 1995, INT J ONCOL, V6, P955
[7]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[8]  
Fujii K, 1996, CANCER EPIDEM BIOMAR, V5, P461
[9]  
Hanada K, 1996, CANCER, V77, P452, DOI 10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO
[10]  
2-M